OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. Various strategies have been employed maximize antibody titer, such as process parameter optimization, genetic engineering, and implementation of perfusion systems. Fine-tuning media compositio